I Wish I Knew What I Know Now: Conversations with AGG on FDA Issues
FDA Regulation of Rx Drug and Medical Device Advertising and Promotion: 2020 Year in Review
Feb 01, 2021Season 1Episode 5
Arnall Golden Gregory LLP
In this episode, AGG’s Food & Drug team leader, Alan G. Minsk, and team member, Genevieve M. Razick, give an overview of FDA’s Office of Prescription Drug Promotion’s (OPDP) enforcement of unlawful advertising in 2020.